Explore a selection of our essential drug information below, or:
Identification
- Summary
Peanut is an extract from Peanut used in allergy testing.
- Brand Names
- Palforzia 12 Mg (level 3), Palforzia 120 Mg (level 7), Palforzia 160 Mg (level 8), Palforzia 20 Mg (level 4), Palforzia 200 Mg (level 9), Palforzia 240 Mg (level 10), Palforzia 3 Mg (level 1), Palforzia 300 Mg (level 11), Palforzia 40 Mg (level 5), Palforzia 6 Mg (level 2), Palforzia 80 Mg (level 6), Palforzia Initial Dose Escalation
- Generic Name
- Peanut
- DrugBank Accession Number
- DB10553
- Background
Peanut allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Food - Plant Source, Peanut Arachis hypogaea Injection, solution 0.1 g/1mL Percutaneous Jubilant Hollisterstier Llc 1941-04-19 Not applicable US 
Food - Plant Source, Peanut Arachis hypogaea Injection, solution 0.1 g/1mL Percutaneous; Subcutaneous Jubilant Hollisterstier Llc 1941-04-19 Not applicable US Palforzia Powder 100 mg Oral Stallergenes 2021-01-12 Not applicable EU 
Palforzia Powder 20 mg/100mg Oral Stallergenes 2021-01-12 Not applicable EU Palforzia Powder 20 mg Oral Stallergenes 2021-01-12 Not applicable EU - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image PALFORZIA (Level 10) Peanut (20 mg/1) + Peanut (100 mg/1) Kit; Powder Oral Aimmune Therapeutics 2020-01-31 Not applicable US PALFORZIA (Level 10) Peanut (20 mg/1) + Peanut (100 mg/1) Kit; Powder Oral Aimmune Therapeutics 2020-01-31 Not applicable US PALFORZIA (Level 3) Peanut (1 mg/1) + Peanut (10 mg/1) Kit; Powder Oral Aimmune Therapeutics 2020-01-31 Not applicable US PALFORZIA (Level 3) Peanut (1 mg/1) + Peanut (10 mg/1) Kit; Powder Oral Aimmune Therapeutics 2020-01-31 Not applicable US PALFORZIA (Level 7) Peanut (20 mg/1) + Peanut (100 mg/1) Kit; Powder Oral Aimmune Therapeutics 2020-01-31 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- QE1QX6B99R
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Percutaneous 0.1 g/1mL Injection, solution Percutaneous; Subcutaneous 0.1 g/1mL Powder Oral 0.5 mg/1mg Powder Oral 1 mg/10mg Powder Oral 1 mg Powder Oral 100 mg Powder Oral 20 mg/100mg Powder Oral 20 mg Powder Oral 300 mg Powder Oral 3 mg/1 Powder Oral 300 mg/1 Powder Oral 6 mg/1 Powder Oral 20 mg/1 Powder Oral 40 mg/1 Powder Oral 80 mg/1 Powder Oral 200 mg/1 Kit; powder Oral Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Percutaneous 0.10 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 17:42